Audentes Therapeutics, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Audentes Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Audentes Therapeutics, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 7,800 | 6,162 | 70,870 | |
| Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.03 | 7,800 | 234,195 | 0 | 7.8 K to 0 (-100.00 %) |
| Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 7,800 | 6,162 | 7,800 | 0 to 7.8 K |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 300 | 237 | 78,670 | |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 1,900 | 1,501 | 78,970 | |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.00 | 300 | 9,000 | 0 | 300 to 0 (-100.00 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 300 | 237 | 300 | 0 to 300 |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.00 | 1,900 | 57,000 | 0 | 1.9 K to 0 (-100.00 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 1,900 | 1,501 | 1,900 | 0 to 1.9 K |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.27 | 6,600 | 193,152 | 62,343 | 68.9 K to 62.3 K (-9.57 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.35 | 18,400 | 521,666 | 68,943 | 87.3 K to 68.9 K (-21.07 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 483 | 14,282 | 3,558 | 4 K to 3.6 K (-11.95 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.32 | 517 | 14,642 | 4,041 | 4.6 K to 4 K (-11.34 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 400 | 11,829 | 20,678 | 21.1 K to 20.7 K (-1.90 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.38 | 600 | 17,028 | 21,078 | 21.7 K to 21.1 K (-2.77 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.46 | 500 | 14,732 | 9,555 | 10.1 K to 9.6 K (-4.97 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.28 | 500 | 14,142 | 10,055 | 10.6 K to 10.1 K (-4.74 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.95 | 1,732 | 51,873 | 405,799 | 407.5 K to 405.8 K (-0.42 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 6,700 | 198,119 | 407,531 | 414.2 K to 407.5 K (-1.62 %) |
| Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.00 | 11,568 | 335,472 | 414,231 | 425.8 K to 414.2 K (-2.72 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.92 | 16,937 | 591,440 | 3,539,997 | 3.6 M to 3.5 M (-0.48 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.04 | 1,066 | 38,419 | 3,556,934 | 3.6 M to 3.6 M (-0.03 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.44 | 11,305 | 411,954 | 3,558,000 | 3.6 M to 3.6 M (-0.32 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 35.86 | 47,395 | 1,699,585 | 3,569,305 | 3.6 M to 3.6 M (-1.31 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.67 | 21,300 | 738,471 | 3,616,700 | 3.6 M to 3.6 M (-0.59 %) |
| Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.06 | 58,428 | 1,990,058 | 3,638,000 | 3.7 M to 3.6 M (-1.58 %) |
| Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 33.03 | 11,372 | 375,617 | 3,696,428 | 3.7 M to 3.7 M (-0.31 %) |
| Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.06 | 200 | 7,212 | 3,707,800 | 3.7 M to 3.7 M (-0.01 %) |
| Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 36.33 | 35,558 | 1,291,822 | 3,708,000 | 3.7 M to 3.7 M (-0.95 %) |
| Mar 06 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 35.06 | 386,080 | 13,535,965 | 3,743,558 | 4.1 M to 3.7 M (-9.35 %) |